公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2018 | Phase II study of BGJ398 in patients with FGFR-Altered advanced cholangiocarcinoma | Javle M.; Lowery M.; Shroff R.T.; Weiss K.H.; Springfeld C.; Borad M.J.; Ramanathan R.K.; Goyal L.; Sadeghi S.; Macarulla T.; El-Khoueiry A.; Kelley R.K.; Borbath I.; Choo S.P.; Oh D.-Y.; Philip P.A.; Chen L.-T.; Reungwetwattana T.; Van Cutsem E.; KUN-HUEI YEH ; Ciombor K.; Finn R.S.; Patel A.; Sen S.; Porter D.; Isaacs R.; Zhu A.X.; Abou-Alfa G.K.; Bekaii-Saab T. | Journal of Clinical Oncology | 511 | 428 | |
2004 | Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma | Lu Y.-S.; CHIUN HSU ; Li C.-C.; Kuo S.-H.; KUN-HUEI YEH ; CHIH-HSIN YANG ; CHIH-HUNG HSU ; Wu C.-Y.; ANN-LII CHENG | Hepato-Gastroenterology | 14 | 13 | |
2019 | Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma | Ta-Chen Huang ; CHIA-CHI LIN ; Wu Y.-C.; CHIA-HSIEN CHENG ; JANG-MING LEE ; HSIU-PO WANG ; PEI-MING HUANG ; Feng-Ming Hsu ; KUN-HUEI YEH ; ANN-LII CHENG ; KAI-YUAN TZEN ; CHIH-HUNG HSU | Journal of the Formosan Medical Association | 8 | 6 | |
1997 | A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers | KUN-HUEI YEH ; ANN-LII CHENG ; Lin M.-T.; RUEY-LONG HONG ; CHIH-HUNG HSU ; Lin J.-F.; KING-JEN CHANG ; PO-HUANG LEE ; YAO-CHANG CHEN | Anticancer Research | 32 | 27 | |
2002 | A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil | CHIH-HUNG HSU ; ANN-LII CHENG ; CHIUN HSU ; CHIH-HSIN YANG ; YEN-SHEN LU ; CHIA-CHI LIN ; Bu C.-F.; KUN-HUEI YEH | Anticancer Research | 12 | 12 | |
2004 | Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer | Chao Y.; KUN-HUEI YEH ; Chang C.J.; Chen L.T.; Chao T.Y.; Wu M.F.; Chang C.S.; Chang J.Y.; Chung C.Y.; Kao W.Y.; Hsieh R.K.; ANN-LII CHENG | British Journal of Cancer | 72 | 63 | |
2005 | Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer | KUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Lin J.-F.; CHIUN HSU ; SUNG-HSIN KUO ; Li Jr. S.; ANN-LII CHENG | Oncology | 22 | 22 | |
2005 | Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer | KUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Lin J.F.; Chao H.J.; Ta-Chen Huang ; Chung C.Y.; Chang C.S.; CHIH-HSIN YANG ; ANN-LII CHENG | British Journal of Cancer | 7 | 7 | |
2007 | A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer | CHIA-CHI LIN ; ANN-LII CHENG ; CHIH-HUNG HSU ; YEN-SHEN LU ; CHIUN HSU ; KUN-HUEI YEH ; Wu C.-Y.; CHIUN-SHENG HUANG ; CHIH-HSIN YANG | Anticancer Research | 2 | 2 | |
2004 | Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death | Yeh P.Y.; Chuang S.-E.; KUN-HUEI YEH ; Song Y.C.; Chang L.L.-Y.; ANN-LII CHENG | Oncogene | 68 | 69 | |
2022 | A pilot study of metabolomic pathways associated with fatigue in patients with colorectal cancer receiving chemotherapy | Chou, Yun-Jen; Kober, Kord M; KUN-HUEI YEH ; Cooper, Bruce A; CHING-HUA KUO ; BEEN-REN LIN ; Kuo, Tien-Chueh; Miaskowski, Christine; YUFENG JANE TSENG | European journal of oncology nursing : the official journal of European Oncology Nursing Society | 3 | 1 | |
2021 | A Pilot Study of Metabolomic Pathways Associated With Fatigue in Survivors of Colorectal Cancer | Chou, Y.-J.; Kober, K.M.; CHING-HUA KUO ; KUN-HUEI YEH ; Kuo, T.-C.; Tseng, Y.J.; Miaskowski, C.; JIN-TUNG LIANG ; YUFENG JANE TSENG | Biological Research for Nursing | 8 | 6 | |
2015 | Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma | JHE-CYUAN GUO ; Ta-Chen Huang ; CHIA-CHI LIN ; MIN-SHU HSIEH ; Chang C.-H.; PEI-MING HUANG ; JANG-MING LEE ; Feng-Ming Hsu ; CHIA-HSIEN CHENG ; HSIU-PO WANG ; KUN-HUEI YEH ; ANN-LII CHENG ; CHIH-HUNG HSU | Journal of Thoracic Oncology | 15 | 16 | |
2013 | Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients | I-CHUN CHEN ; CHIUN HSU ; Chen Y.C.; Chien S.F.; HSIANG-FONG KAO ; Chang S.Y.; Hu F.C.; KUN-HUEI YEH | Annals of Oncology | 32 | 29 | |
1995 | Primary T cell leptomeningeal lymphoma – Successful treatment with systemic chemotherapy | KUN-HUEI YEH ; ANN-LII CHENG ; HWEI-FANG TIEN | Oncology (Switzerland) | 14 | 9 | |
2016 | Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: A nationwide cohort study | KUO-HSING CHEN ; YU-YUN SHAO ; Chen H.-M.; Lin Y.-L.; ZHONG-ZHE LIN ; Lai M.-S.; ANN-LII CHENG ; KUN-HUEI YEH | BMC Cancer | 39 | 39 | |
2013 | Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy | WEI-WU CHEN ; CHIA-CHI LIN ; TA-CHEN HUANG ; ANN-LII CHENG ; KUN-HUEI YEH ; CHIH-HUNG HSU | Anticancer Research | 11 | 11 | |
1997 | Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas | KUN-HUEI YEH ; ANN-LII CHENG ; Su I.H.-J.; Lin M.-T.; HWEI-FANG TIEN ; MING-CHING SHEN ; Wang C.-H.; YAO-CHANG CHEN | Anticancer Research | 20 | 14 | |
2000 | Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil | KUN-HUEI YEH ; Shiou-Hwei Yeh ; CHIH-HUNG HSU ; TONG-MEI WANG ; Ma I.-F.; ANN-LII CHENG | British Journal of Cancer | 26 | | |
2021 | Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells | YI-HSIN LIANG ; KUO-HSING CHEN ; JIA-HUEI TSAI ; Cheng, Yung-Ming; Lee, Chang-Cheng; Kao, Chiu-Hwa; Chan, Kuang-Yu; Chen, Yeh-Ting; Hsu, Wen-Ling; KUN-HUEI YEH | Journal of biomedical science | 7 | 6 | |